Search results for “Granulocyte Elastase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 412 patents, we discovered top 62 key players by total patent application. Boehringer Ingelheim International GmbH, CHIESI Farmaceutici SpA, AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 39.08% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 60
CHIESI Farmaceutici SpA
Emilia-Romagna, Italy
Patent: 55
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 46
Spexis Ltd.
Basel-Landschaft, Switzerland
Patent: 41
Astute Medical, Inc.
California, United States
Patent: 19
Cortech, Inc.
New Jersey, United States
Patent: 19
Novartis AG
Basel-Stadt, Switzerland
Patent: 18
Dyax Corp.
Massachusetts, United States
Patent: 16
Zeneca Garden Care
CHESHIRE, United Kingdom
Patent: 13
ARKRAY, Inc.
Kyoto-fu, Japan
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
STARTUP
pH Pharma Co., Ltd.
South Korea
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing Spexis Ltd., CHIESI Farmaceutici SpA, Regents of The University of Michigan take 55.88% of patent filing during this period.
Spexis Ltd.
Basel-Landschaft, Switzerland
Patent: 8
CHIESI Farmaceutici SpA
Emilia-Romagna, Italy
Patent: 6
Regents of The University of Michigan
Michigan, United States
Patent: 5
Board of Regents of The University of Oklahoma
Oklahoma, United States
Patent: 4
Mereo BioPharma 4 Ltd.
United Kingdom
Patent: 3
Nordic Bioscience A/S
Hovedstaden, Denmark
Patent: 2
Maruzen Pharmaceuticals Co., Ltd.
Hiroshima-ken, Japan
Patent: 1
Chemland Co., Ltd.
South Korea
Patent: 1
Université de Paris
France
Patent: 1
STARTUP
pH Pharma Co., Ltd.
South Korea
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 11 new entrants. Regents of The University of Michigan, Board of Regents of The University of Oklahoma, Mereo BioPharma 4 Ltd. are the most active new entrants in this area.
Regents of The University of Michigan
Michigan, United States
Patent: 5
Board of Regents of The University of Oklahoma
Oklahoma, United States
Patent: 4
Mereo BioPharma 4 Ltd.
United Kingdom
Patent: 3
Nordic Bioscience A/S
Hovedstaden, Denmark
Patent: 2
Fondation Ophtalmologique Adolphe de Rothschild
France
Patent: 1
Guangzhou Women & Childrens Medical Center
Guangdong Sheng, China
Patent: 1
Maruzen Pharmaceuticals Co., Ltd.
Hiroshima-ken, Japan
Patent: 1
Chemland Co., Ltd.
South Korea
Patent: 1
The University of Chicago
Illinois, United States
Patent: 1
Université de Paris
France
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 23 patents, we discovered top 5 universities and scientific research institutions by total patent application. The University of Chicago, University of Lisbon, Shanxi University are dominant in this area. They take 56.52% of the total patent filing.
The University of Chicago
Illinois, United States
Patent: 1
University of Lisbon
Lisboa, Portugal
Patent: 1
Shanxi University
Shanxi Sheng, China
Patent: 1
Meijo University
Aichi-ken, Japan
Patent: 1
Université de Paris
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: